Search for: "Fast et al v. Johnson & Johnson, Inc. et al"
Results 1 - 20
of 22
Sort by Relevance
|
Sort by Date
31 May 2021, 9:02 am
SHC Laguna Niguel I, LLC et al, 2021 WL 2165208 (C.D. [read post]
17 Mar 2020, 1:32 pm
NEUTROGENA® and AVEENO® Aerosol Sunscreen Products have been recalled by Johnson & Johnson Consumer Inc. due to the presence of benzene. [read post]
27 Jan 2016, 1:34 pm
Johnson & Johnson Services, Inc. et al 3:11-cv-01941). [read post]
31 Aug 2014, 12:49 pm
In dissent in Petrella v. [read post]
19 Dec 2012, 4:08 pm
Psychiatry Piquero, Alex R., et al. [read post]
29 May 2012, 10:02 am
That case (Tessera, Inc., v. [read post]
30 Apr 2012, 11:19 am
James III, et al. [read post]
2 Apr 2012, 6:15 am
(In case you’re wondering, the remaining five are Microsoft, Pfizer, Exxon-Mobil, Johnson & Johnson and ADP.) [read post]
11 Apr 2011, 4:19 am
Johnson & Johnson, et. al. [read post]
7 Feb 2011, 2:58 am
jovický Budvar, národní podnik v Anheuser-Busch, Inc. [read post]
1 Nov 2010, 2:46 am
DIRECTV, Inc., et al. [read post]
30 Jul 2010, 3:13 am
Clover Staffing, LLC and Johnson Controls World Services, Inc., et al., 238 F.R.D. 576, 579 (S.D. [read post]
24 Jan 2010, 5:54 pm
The case, Danielle Johnson, Individually, et al. v. [read post]
27 Jul 2009, 7:18 am
Wal-Mart Stores Inc, et al (Peter Zura's 271 Patent Blog) District Court N D Illinois: Inventor/plaintiff’s Managing Director not given highly confidential technical information: McDavid Knee Guard Inc v Nike USA Inc (Chicago Intellectual Property Law Blog) District Court E D Pennsylvania: Warsaw Orthpedic awarded $2M in Globus patent dispute (Patent Docs) District Court E D Texas: ‘I have good cause but it’s a… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
23 Jan 2009, 1:00 am
(Managing Intellectual Property) (Law360) (Out-Law) ECJ rules German music distributor cannot sell two Bob Dylan compilation albums because Sony owns rights to songs in question: Sony Music Entertainment (Germany) GmbH v Falcon Neue Medien Vertrieb GmbH (IPKat) (Law360) ECJ: Date set for Advocate General’s opinion in L'Oréal SA, Lancôme parfums et beauté & Cie SNC, Laboratoire Garnier & Cie v Bellure… [read post]
7 Nov 2008, 3:57 am
Political flurries and potential trade mark wars (Afro-IP) House arrest for DVD pirate (Afro-IP) Spain Government to publish ‘Manual of Best Practices in the Prosecution of Infringing Activities’ (Class 46) Ukraine Trade marks database to be accessible free of charge (Class 46) United Arab Emirates Limitations on trademark protection (International Law Office) United Kingdom Financing creative businesses (IP finance) UK patent… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
